Program

88
44
8
2
2

Journal Year Published

7
19
9
15
13
13
7
3
10
7
4
2

Author

109
61
49
43
20
20
15
15
15
15
15
14
14
13
13
13
13
11
11
11

Category

56
44
30
15
7
4
4
2
1
1

Keyword

58
32
24
22
18
16
15
14
12
11
11
11
10
9
9
9
9
8
8
7

Journal

13
8
5
4
4
4
4
3
3
3
2
2
2
2
2
2
2
2
2
2

NCATS Publications

Development of an Aryloxazole Class of Hepatitis C Virus Inhibitors Targeting the Entry Stage of the Viral Replication Cycle.


He S, Li K, Lin B, Hu Z, Xiao J, Hu X, Wang A, Xu X, Ferrer-Alegre M, Southall N, Zheng W, Aubé J, Schoenen FJ, Marugan J, Liang TJ, Frankowski KJ


J. Med. Chem. , (60), 6364-6383, 2017.

Article Pubmed
Sample image from publication page

SU9516 Increases α7β1 Integrin and Ameliorates Disease Progression in the mdx Mouse Model of Duchenne Muscular Dystrophy.


Sarathy A, Wuebbles RD, Fontelonga TM, Tarchione AR, Mathews Griner LA, Heredia DJ, Nunes AM, Duan S, Brewer PD, Van Ry T, Hennig GW, Gould TW, Dulcey AE, Wang A, Xu X, Chen C, Hu X, Zheng W, Southall N, Ferrer-Alegre M, Marugan J, Burkin DJ


Mol. Ther. , 2017.

Article Pubmed
Sample image from publication page

Synergistic drug combination effectively blocks Ebola virus infection.


Sun W, He S, Martínez-Romero C, Kouznetsova J, Tawa G, Xu M, Shinn P, Fisher EG, Long Y, Motabar O, Yang S, Sanderson P, Williamson PR, García-Sastre A, Qiu X, Zheng W


Antiviral Res. , (137), 165-172, 2017.

Article Pubmed
Sample image from publication page

ML372 blocks SMN ubiquitination and improves spinal muscular atrophy pathology in mice.


Abera MB, Xiao J, Nofziger J, Titus S, Southall N, Zheng W, Moritz KE, Ferrer-Alegre M, Cherry JJ, Androphy EJ, Wang A, Xu X, Austin C, Fischbeck KH, Marugan J, Burnett BG


JCI Insight , (1), e88427, 2016.

Article Pubmed
Sample image from publication page